Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
174.80
+2.80 (1.63%)
May 29, 2025, 3:11 PM AST
31.83%
Market Cap 12.24B
Revenue (ttm) 1.39B
Net Income (ttm) 410.59M
Shares Out 70.00M
EPS (ttm) 5.87
PE Ratio 29.80
Forward PE 27.60
Dividend 3.06 (1.75%)
Ex-Dividend Date Mar 5, 2025
Volume 56,528
Average Volume 66,714
Open 173.40
Previous Close 172.00
Day's Range 171.20 - 175.00
52-Week Range 128.80 - 202.40
Beta n/a
RSI 57.28
Earnings Date Aug 11, 2025

About TADAWUL:4015

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdo... [Read more]

Sector Healthcare
Founded 1994
Country Saudi Arabia
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4015
Full Company Profile

Financial Performance

In 2024, TADAWUL:4015's revenue was 1.32 billion, an increase of 19.77% compared to the previous year's 1.10 billion. Earnings were 356.52 million, an increase of 21.93%.

Financial Statements

News

There is no news available yet.